Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omarigliptin PK and Extraction in Healthy Volunteers
NCT04365907Unknown
- Sponsor
- The British University in Egypt
- Start
- Mar 2020
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of omarigliptin in type 2 diabetes mellitus (T2DM), sponsored by The British University in Egypt. Primary endpoint: Plasma concentration of Omarigliptin at 1.5 hours. Status: unknown.
02
Drugs
omarigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04365907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04365907.